Thomas O’Sullivan takes first, Tengfei Luo second, in 1st Source Bank Commercialization Awards
Thomas O’Sullivan, associate professor of electrical engineering at the University of Notre Dame, is the first-place winner of the 2023 1st Source Bank Commercialization Award. Tengfei Luo, the Dorini Family Professor for Energy Studies, placed second. The first-place award carries a $25,000 cash prize, while the runner-up award is $10,000.
O’Sullivan co-founded NearWave, a non-invasive handheld medical device that helps physicians select the right therapy for breast cancer patients. The hand-held imaging device can tell in under a week if a treatment is working, rather than having patients wait six to 12 months and potentially suffering through toxic side effects. The NearWave device may also reduce the number of biopsies required for breast cancer by enabling imaging in OB-GYN and primary care offices.
The concept for NearWave started in a graduate class taught by O’Sullivan. He and co-founder Roy Stillwell worked on NearWave with the O’Sullivan Research Group in the Biomedical Photonics Laboratory at Notre Dame.
NearWave’s technology has shown promising results in the ability to differentiate benign from malignant tumors non-invasively with 90 percent specificity and sensitivity.
“I am humbled and honored to be counted among the current nominees and past recipients of this award,” said O’Sullivan. “I am also grateful for the incredible support and encouragement since my arrival at Notre Dame. Thank you to Notre Dame’s Electrical Engineering department and the College of Engineering for building us a lab that allowed us to do, for the first time, clinical studies of a Notre Dame-developed medical device on campus. Thanks also to the Harper Cancer Research Institute and the Berthiaume Institute for Precision Health for seeding core technologies in the NearWave scanner. Thanks also to the College of Science. In addition, Notre Dame and St. Joseph Health have been incredible partners that have allowed NearWave to safely perform our research.”
NearWave has raised $1.5 million in outside investment and has an open seed round with several investors. Currently, the device is available to researchers in oncology, women's health, traumatic brain injury research and optics-related groups.
Emerging from the Molecular/Nano-Scale Transport and Energy Research (MONSTER) Laboratory at Notre Dame, Luo’s technology led to the founding of Tessellated Inc., a polymer film company that uses a patented formula to produce some of the most robust polymer materials in the world. This versatile material offers a multitude of potential uses from ballistic armor and sport gears to thermal management. It can be incorporated into composite components for both aerospace and automotive sectors.
Tessellated’s formation was driven by Luo and his team’s identification of a market opportunity leveraging the novel properties of this material. The material is being explored for protecting satellites and spacecraft from space debris and the optimization of thermal regulation in energy systems, specifically within electric vehicles. Tessellated aspires to broaden its impact across various industries that can implement its polymer thin film technology.
Tessellated has received multiple STTR Phase I grants from the U.S. Department of Energy, the U.S. Army and the U.S. Air Force. Additionally, the company secured a Phase II grant from the Army spanning two years. Tessellated has also secured investments from an Indiana-based venture capital firm.
“I am very privileged and grateful to be selected for such a prestigious award, let alone winning it!” said Luo. “It is great to see the transition from my fundamental research to a product that can potentially impact society.”
Established in 2008 with a $1 million gift from 1st Source Bank, the Commercialization Award is presented annually to faculty from Notre Dame or the Indiana University School of Medicine-South Bend who have successfully transitioned their technologies from the lab to the marketplace.
Latest Faculty & Staff
- In memoriam: Charles Kulpa, professor emeritus of biological sciencesCharles “Chuck” Frank Kulpa, professor emeritus in the Department of Biological Sciences, died April 30 in South Bend. He was 80. Kulpa was a respected scholar and professor of environmental and applied microbiology for 40 years.
- Disadvantaged entrepreneurs often fear success, but new research can helpWhen low-income entrepreneurs start their own businesses, they frequently fear failure — a well-documented phenomenon. But over time, they may also fear success, given the costs and unknowns it can bring, and this barrier to growth is under-studied and underappreciated. A new study from a Keough School of Global Affairs expert breaks new ground by explaining this fear and offers five recommendations to help entrepreneurs overcome it and move out of poverty.
- Mary Gallagher appointed dean of the University of Notre Dame’s Keough School of Global AffairsMary Gallagher, the Amy and Alan Lowenstein Chair in Democracy, Democratization and Human Rights and director of the International Institute at the University of Michigan, has been appointed the Marilyn Keough Dean of the Keough School of Global Affairs by University President Rev. John I. Jenkins, C.S.C. Gallagher, who will also hold a tenured faculty position in the Keough School, begins her five-year term as dean on July 1.
- Opioid epidemic reaches beyond health impacts to influence politicsVicky Barone, assistant professor of economics at Notre Dame, researched the origins and development of the opioid epidemic and found that the unregulated marketing of potent painkillers led to increased access to prescription opioids and subsequent overdose mortalities. Tracing the long-term consequences of opioid overdose deaths on the political landscape in America, she found an increased support for conservative beliefs and Republican candidates.
- Doug Thompson appointed inaugural executive director of diversity and engagementDoug Thompson, current vice president for equity and inclusion at Gustavus Adolphus College, has been appointed as the inaugural executive director of diversity and engagement in the University of Notre Dame’s Division of Student Affairs, effective July 1.
- There’s no ‘one size fits all’ when it comes to addressing men’s health issues globallyAt a time when health resources are at a premium and need to be wisely allocated, health professionals must find points within men’s lives when it makes the most sense to intervene and advocate for preventive care for promoting better health outcomes. Life transitions such as marriage and fatherhood are often pivotal and crucial intervention points. But just like every man is different, health concerns across global communities differ as well. Research from the University of Notre Dame finds that not all life transitions produce the same health results, and not all men’s global health policies should look the same from one country to another.